UNSPSC 51381904: Oxolamine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51381904

Definition

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H19N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 90BEA145GY, chemically known as 1,2,4-oxadiazole, 5-(2-(diethylamino)ethyl)-3-phenyl- but generally known as oxolamine, which bears US NIH Compound Identifier 13738. European Medicines Agency schedules Oxolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09547MIG. The term OXOLAMINE is an International Non-Proprietary Name.

Read the full definition

World Health Organization schedules oxolamine in its Anatomical Therapeutic Chemical (ATC) Classification. OXOLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxolamine under HS 29349990 and SITC 51579. As of Q4 2014, OXOLAMINE remains the US FDA Preferred Term for this commodity. Oxolamine bears US NLM identifiers UMLS ID C0069787 and NCI Concept Code C66274. SMILES: O1NC(NC1CCN(CC)CC)C1CCCCC1.

About UNSPSC 51381904

UNSPSC 51381904 Oxolamine is a Commodity code for pharmaceutical products, though recent state and local solicitations under this code show procurement of naloxone and drug deactivation systems rather than oxolamine specifically. Naloxone—an opioid antagonist used in overdose response and community health initiatives—represents the primary product category being acquired by state and local health agencies. The issuing bodies soliciting under this code span county health departments and community health systems focused on emergency medical preparedness and substance-abuse intervention. Procurements require vendors to supply annual quantities with quarterly delivery schedules, include all transportation costs in pricing, maintain appropriate insurance and workplace certifications, and comply with federal regulations when FEMA or other federal funding streams are involved.

Seminole County, Florida has posted recent activity under this code: an IFB (Invitation for Bid) issued June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a response deadline of July 26, 2023. The solicitation requires electronic submission through the county's e-Procurement Portal, unit cost bidding for each line item, E-Verify employment verification, drug-free workplace certification, and standard commercial general liability and workers' compensation insurance. The initial contract term is two years with an optional one-year renewal, includes a three-month probationary termination clause, and may carry FEMA funding compliance requirements. Recent solicitation activity appears concentrated in Florida, though the sparse opportunity sample limits characterization of broader geographic distribution.

Quick answers

What is UNSPSC 51381904?

UNSPSC 51381904 is Oxolamine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51381904?

UNSPSC 51381904 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51381904

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code